From: Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
Patient number | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Mean | CV (%) |
Rate of the 12-h initial infusion (μg/kg/h) | 0.1 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6a | 58.1 |
Maximum infusion rate (μg/kg/h) | 0.1 | 2.1 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 0.95 | 0.7 | 2.5 | 1.2 | 2.5 | 2.5 | 1.5a | 117 |
Length of infusion (h) | 40 | 142 | 137 | 88 | 55 | 304 | 137 | 30 | 121 | 330 | 13 | 72 | 192 | 92.0a | 117 |
Cumulative dose (mg) | 0.34 | 11 | 25 | 8.7 | 8.0 | 56 | 17 | 1.4 | 2.4 | 82 | 1.1 | 13 | 46 | 21.0 | 120 |
AUC0-∞ (ng h/ml) | 17.8 | 376 | 550 | 174 | 252 | 924 | 337 | 39.0 | 100 | 1,530 | 29.7 | 350 | 583 | 213a | 233 |
Extrapolated fraction of AUC0-∞ (%) | 1.3 | 0.1 | 0.0 | 0.1 | 22.0 | 0.0 | 0.0 | 0.6 | 0.2 | 0.0 | 37.1 | 9.3 | 0.0 | ||
t1/2 (h) | 4.5 | 4.2 | 2.9 | 5.0 | - | 2.4 | 3.4 | 3.3 | 6.9 | 5.1 | - | - | 2.1 | 3.7a | 38.1 |
Cl (L/h) | 18.9 | 30.4 | 45.4 | 50.4 | 31.8 | 60.7 | 51.5 | 35.5 | 23.7 | 53.7 | 36.1 | 36.7 | 79.0 | 39.7a | 40.9 |
V (L) | 123 | 184 | 193 | 362 | - | 213 | 252 | 170 | 234 | 391 | - | - | 234 | 223a | 35.3 |